Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute

Artificial Organs

Volumn 28, Issue 5, 2004, Pages 444-450

  Kashiwa, Naohiro ^a   Ito, Osamu ^a   Ueda, Takeshige ^a   Kubo, Kentaro ^b   Matsui, Hiromichi ^b   Kuroyanagi, Yoshimitsu ^b  

^a KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Collagen; Cultured dermal substitute; Fibroblasts; Hyaluronic acid; Mesh skin grafting

Indexed keywords

CELL CULTURE; COLLAGEN; HYALURONIC ACID; MESH GENERATION; ORGANIC ACIDS; TISSUE;

CLINICAL STUDY; CULTURED DERMAL SUBSTITUTES; DEEP BURN; EPITHELIZATION; MATRIX; MESH SKIN GRAFTING; SKIN DEFECTS; SKIN GRAFT; SKIN GRAFTING;

FIBROBLASTS;

ATELOCOLLAGEN; HYALURONIC ACID;

AGED; ALLOGRAFT; ANAMNESIS; ARTICLE; ARTIFICIAL SKIN; BURN; CELL CULTURE; CLINICAL ARTICLE; CLINICAL FEATURE; DEBRIDEMENT; EPITHELIZATION; EVALUATION; FEMALE; FIBROBLAST; FULL THICKNESS SKIN GRAFT; HUMAN; MALE; PRIORITY JOURNAL; SURGICAL EQUIPMENT;

EID: 2542479285     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2004.00009.x     Document Type: Article

References (31)

1. Rheinwald JG, Green H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 1975;6:317-30.
2. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975;6:331-43.
3. Green H, Kehinde O, Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979;76:5665-8.
4. Gallico G, O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 1984;11:448-51.
5. Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel RI, Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991;12:243-8.
6. Hansbrough JF, Christine D, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992;13:519-29.
7. Hansbrough JF, Cooper ML, Cohen R, Spielvogel R, Greenleaf G, Bartel RL, Naughton G. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery 1992;111:438-46.
8. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-4.
9. Hansbrough JF, Mozingo DW, Kealey GP, Davis M, Gidner A, Gentzkow GD. Clinical trials of a biosynthetic temporary skin replacement, dermagraft-transitional covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J Burn Care Rehabil 1997;18:43-51.
10. Hansbrough JF, Morgan J, Greenleaf G. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material. Surgery 1994;115:633-44.
11. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 1979;211:1274-8.
12. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981;211:1052-4.
13. Bell E, Ehrlich HP, Sher S, et al. Development and use of a living skin equivalent. Plast Reconstr Surg 1981;67:386-92.
14. Bell E, Sher S, Hull B, et al. The reconstitution of living skin. J Invest Dermatol 1983;81:2s-10s.
15. Naughton G. The advanced tissue sciences story. Sci Am 1999;April:60-1.
16. Yamada N, Shioya N, Kuroyanagi Y. Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing. Scand J Plast Reconstr Surg 1995;29:211-19.
17. Tanaka M, Nakakita N, Kuroyanagi Y. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test. J Biomater Sci Polymer Edn 1999;10:433-53.
18. Yamada N, Uchinuma N, Kuroyanagi Y. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scand J Plast Reconstr Surg 1999;33:147-54.
19. Kuroyanagi Y, Yamada N, Yamashita R, Uchinuma E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 2001;25:180-6.
20. Kuroyanagi Y, Kubo K, Matsui H, Kagawa S, Mori S, Kim HJ, Mabuchi Y. Manufacturing and banking system for allogeneic cultured dermal substitute. Jpn J Burn Injuries 2003;29: 28-38.
21. Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen for cultured dermal substitute; evaluation in animal test. J Artif Organs 2003;6:64-70.
22. Kubo K, Kuroyanagi Y. Characterization of cultured dermal substitute composed of spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 2003;6:138-44.
23. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of hyaluronic acid and collagen combined with fibroblasts; Fundamental evaluation. J Biomater Sci Polymer Edn 2003;14:625-41.
24. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts; cryopreservation. Artif Organs 2004;28:182-8.
25. Kubo K, Kuroyanagi Y. Effects of VEGF released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro. J Artif Organs 2003;6:267-72.
26. Oka H, Fujitsu M, Suenobu K, et al. Clinical trials with allogeneic cultured dermal substitute (CDS) for the treatment of burns and skin ulcers. Jpn J Burn Injuries 2002;28:333-42.
27. Harima N, Ansai S, Wako M, et al. Clinical trials using allogeneic cultured dermal substitutes for skin ulcers. Jpn J Dermatol 2003;113:253-64.
28. Fujimori Y, Ueda K, Omiya Y, Kubo K, Kuroyanagi Y. Cllinical trials with allogeneic cultured dermal substitute (CDS) for full-thickness skin defects. J Jpn PRS 2003;23:475-84.
29. Culp LA, Murray BA, Rollins BJ. Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct 1979;11:401-27.
30. Benedetti L, Cortivo R, Berti T, et al. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomater 1993;14:1154-60.
31. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 1978;75: 871-5.